Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schmitt-Egenolf

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
The British Journal of Dermatology|October 8, 2020
Complete skin clearance and beyondM Schmitt-Egenolf
The British Journal of Dermatology|February 15, 2018
What can we learn from 'dropouts' in clinical trials?M Schmitt-Egenolf
The British Journal of Dermatology|September 17, 2016
Physical activity and lifestyle improvement in the management of psoriasisM Schmitt-Egenolf
The British Journal of Dermatology|December 1, 2015
Evaluating equality in psoriasis healthcare: a cohort study of the impact of age on prescription of biologicsK Geale, M Henriksson, M Schmitt-Egenolf
The British Journal of Dermatology|June 24, 2017
Sustained Psoriasis Area and Severity Index, Dermatology Life Quality Index and EuroQol-5D response of biological treatment in psoriasis: 10 years of real-world data in the Swedish National Psoriasis RegisterF Hjalte, K S Carlsson, M Schmitt-Egenolf
The British Journal of Dermatology|April 1, 2021
Prevalence and incidence of palmoplantar pustulosis in Sweden: a population-based register studyS Löfvendahl, J M Norlin, M Schmitt-Egenolf
Journal of the European Academy of Dermatology and Venereology : JEADV|June 10, 2014
Decision for biological treatment in real life is more strongly associated with the Psoriasis Area and Severity Index (PASI) than with the Dermatology Life Quality Index (DLQI)D Hägg, A Sundström, M Eriksson, et al.
The British Journal of Dermatology|July 21, 2019
Complete skin clearance and Psoriasis Area and Severity Index response rates in clinical practice: predictors, health-related quality of life improvements and implications for treatment goalsJ M Norlin, K Nilsson, U Persson, et al.
The Journal of Dermatological Treatment|January 31, 2017
Real-world outcomes in 2646 psoriasis patients: one in five has PASI ≥10 and/or DLQI ≥10 under ongoing systemic therapyJ M Norlin, P S Calara, U Persson, et al.
The British Journal of Dermatology|December 21, 2011
Analysis of three outcome measures in moderate to severe psoriasis: a registry-based study of 2450 patientsJ M Norlin, K Steen Carlsson, U Persson, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
The British Journal of Dermatology|October 8, 2020
Complete skin clearance and beyondM Schmitt-Egenolf
The British Journal of Dermatology|February 15, 2018
What can we learn from 'dropouts' in clinical trials?M Schmitt-Egenolf
The British Journal of Dermatology|September 17, 2016
Physical activity and lifestyle improvement in the management of psoriasisM Schmitt-Egenolf
The British Journal of Dermatology|December 1, 2015
Evaluating equality in psoriasis healthcare: a cohort study of the impact of age on prescription of biologicsK Geale, M Henriksson, M Schmitt-Egenolf
The British Journal of Dermatology|June 24, 2017
Sustained Psoriasis Area and Severity Index, Dermatology Life Quality Index and EuroQol-5D response of biological treatment in psoriasis: 10 years of real-world data in the Swedish National Psoriasis RegisterF Hjalte, K S Carlsson, M Schmitt-Egenolf
The British Journal of Dermatology|April 1, 2021
Prevalence and incidence of palmoplantar pustulosis in Sweden: a population-based register studyS Löfvendahl, J M Norlin, M Schmitt-Egenolf
Journal of the European Academy of Dermatology and Venereology : JEADV|June 10, 2014
Decision for biological treatment in real life is more strongly associated with the Psoriasis Area and Severity Index (PASI) than with the Dermatology Life Quality Index (DLQI)D Hägg, A Sundström, M Eriksson, et al.
The British Journal of Dermatology|July 21, 2019
Complete skin clearance and Psoriasis Area and Severity Index response rates in clinical practice: predictors, health-related quality of life improvements and implications for treatment goalsJ M Norlin, K Nilsson, U Persson, et al.
The Journal of Dermatological Treatment|January 31, 2017
Real-world outcomes in 2646 psoriasis patients: one in five has PASI ≥10 and/or DLQI ≥10 under ongoing systemic therapyJ M Norlin, P S Calara, U Persson, et al.
The British Journal of Dermatology|December 21, 2011
Analysis of three outcome measures in moderate to severe psoriasis: a registry-based study of 2450 patientsJ M Norlin, K Steen Carlsson, U Persson, et al.
Pageof 3